A shocking counterfeit drug racket has been busted in Gurugram, where fake injections branded as Mounjaro—a globally popular diabetes and weight-loss drug developed by Eli Lilly—were being manufactured and circulated.The case has exposed how a high-demand medical product turned into a profitable black-market commodity, putting countless lives at risk.
The Mastermind: Avi Sharma and His ‘Home-Made’ Drug Network
At the center of the operation is Avi Sharma, now absconding, who allegedly ran the entire counterfeit setup from his own residence.According to police inputs, Avi did not operate from any licensed facility. Instead, he reportedly prepared fake injections at home, mimicking the original drug’s appearance, packaging, and branding.Investigators believe he used cheap chemical mixtures and substitute substances to replicate the look and feel of the original injection, turning a residential space into a covert production unit.This was not just small-scale tampering — it was a calculated attempt to replicate a premium international drug and sell it at high margins.
Supply Chain: From Home to Market
The racket extended beyond production. Avi Sharma allegedly built a small distribution chain, using associates to move the fake stock into the market.
One such link, Mujammil Khan, a taxi driver, has been arrested. Police suspect that transportation and delivery were being handled discreetly to avoid detection, indicating a structured yet underground network.
Why ‘Mounjaro’ Became a Target
Originally developed for diabetes treatment, Mounjaro has rapidly gained popularity as a weight-loss drug, making it one of the most sought-after medicines globally.With each dose priced between Rs 13,000 and Rs 25,000, the drug became an easy target for counterfeiters looking to exploit high demand and limited availability.Just like cough syrups were misused in the past, this injection is now being misused and over-demanded beyond medical necessity, creating a perfect environment for illegal trade.
A Silent Health Hazard
The biggest danger lies in what these fake injections may contain. Without proper formulation, quality checks, or clinical safety, such counterfeit drugs can lead to severe health complications, treatment failure, or life-threatening reactions.For patients relying on this medication, the risk is not just financial — it is deeply personal and potentially fatal.
Bigger Threat: Rise of ‘Home-Made Pharma Crime’
This case highlights a disturbing trend — illegal drug manufacturing shifting into small, hidden setups, making detection harder.Instead of large factories, operations are now being run from homes or small units, using easily accessible materials and digital channels to reach buyers.
The Big Question
If a high-end international drug can be copied inside a home and pushed into the market, it raises a serious question —
how many such networks are still operating unnoticed?
